According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations. 

AstraZeneca also plans to revoke marketing authorisations for its vaccine, Vaxzevria, within Europe due to reduced demand and discontinuation of production and..

AstraZeneca withdraws COVID vaccine worldwide due to TTS. Facing 100 million pound lawsuit. TTS involves blood clots, low platelets. Symptoms: severe headache,..

Recent concerns regarding potential links between the Covishield vaccine and blood clots have sparked widespread discussion. Amidst this, Bollywood actor Shreyas..

Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS),..

Prominent vaccine manufacturer Astra Zeneca acknowledged in a court filing that TTS, a disorder that can result in blood clots and low platelet counts, can be..

In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its..

Covishield was developed by AstraZeneca in collaboration with the Oxford University during the COVID-19 pandemic

AstraZeneca admits Covishield's rare side effect TTS, causing blood clots with low platelets. TTS symptoms include severe headaches, abdominal pain. Treatment..

He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.

The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)..

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)..

The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly..

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to..

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of..

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had..

Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for..

In the reply to an RTI filed by a Pune businessman, ICMR and CDSCO have admitted to multiple side effects of Covid-19 vaccination and the Covishield which was..

The study was conducted on the participants who had received the booster dose of the Covishield vaccination.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a..

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken..

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days,..

Govt-run centres only have Covaxin; state writes to Centre seeking Covishield, Corbevax

Bharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for..

Noida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.

The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.

Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic...

With interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin left

"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100..

Amid shortage of Covishield doses, civic officials offer Corbevax, but people are hesitant to take the brand’s COVID vaccine

The petitioner blamed the authorities for creating false narratives about the Covishield vaccine. He has sought compensation of Rs 1,000 crore.

Those adults who got vaccinated with either Covaxin or Covishield will now be allowed to take the Corbevax dose, six months or 26 weeks after administration of..

India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main..

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in India.

In what is the first heterologous booster shot to be approved, Biological E’s Covid-19 vaccine Corbevax is learnt to have received the government’s nod for..

 This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

government panel on Covid immunisation has recommended allowing Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield..

The Union health ministry has asked global vaccine alliance GAVI to supply 5 crore of the allocated 10 crore doses of Covishield to India under the COVAX..

NTAGI is considering using Corbevax as a booster vaccination against Covid-19.

Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the..

Monkeypox outbreak: Social media posts claiming the chimpanzee adenovirus vector used in AstraZeneca's Covid vaccine, causes Monkeypox have surfaces, PTI..

There were 416 patients aged 18 to 80 who got two doses of Covaxin or Covishield, the last one six months before the Corbevax booster.

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two..

A probe has been ordered after several vials of Covishield vaccine were found in a garbage dump at a community health centre, reports PTI.

Thousands of NRIs, who are back in India after taking Covid vaccines other than Covishield or Covaxin, now face a unique problem: they are unable to get the..

The patient received the first dose of Covishield vaccine on January 31, 2021, and the second dose on March 3, 2021.

A study of vaccine effectiveness against SARS-CoV-2 variants has found that Covishield recipients with no history of Covid had the lowest levels of neutralizing..

The Bombay high court frowned at the state government for not deciding on the representation of a hospital in Nalasopara (E) that has surplus Covishield vaccine..